Record Sales Of Therapeutic Antibodies in 2021 Pushed by Immuno-Oncology, Novel Anti-Inflammatory and Anti-SARS-CoV-2 Antibodies
BARCELONA, Spain I March 16, 2021 I La Merie Publishing released the 16th edition of its annual report about sales…
Targeted Protein Degradation (TPD) by proteasomal PROTACs & molecular glues, lysosomal LYTACs and autophagic AUTOTACs or ATTECs provides plenty of opportunities to drug undruggable targets
BARCELONA, Spain I March 07, 2022 I La Merie Publishing released today its newest report entitled “Targeted Protein Degradation by…
Targeted Protein Degradation (TPD) is emerging as a key technology to overcome limitations of conventional drug modalities and unlock the undrugged proteome
BARCELONA, Spain I March 07, 2022 I La Merie Publishing announced today the launch of the 2nd edition of its…
Prodrug antibodies and cytokines generated by masking technologies provide plenty of opportunities for founders, investors and partnerships
BARCELONA, Spain I October 06, 2021 I La Merie Publishing announced the release of its newest report about antibody and…
Masked Antibodies and Cytokines as Prodrugs: strongly emerging novel technologies providing plenty of opportunities for founders, investors and partnerships
BARCELONA, Spain I October 06, 2021 I La Merie Publishing announced the release of its newest report about antibody and…
Vectorized Antibodies for In Vivo Expression by DNA and mRNA: an emerging new technology
BARCELONA, Spain I July 1, 2021 I La Merie Publishing announced the release of its newest report about in vivo…
Landscape Analysis of Targeted Protein Degradation by Novel PROTACs and Molecular Glues
BARCELONA, Spain I May 14, 2020 I La Merie Publishing announced the release of its newest report about Targeted Protein…
The growing field of bispecific T-cell and NK cell engaging antibodies offers great opportunities for technology and product development companies
June 11, 2019 I We just released a new report describing and analyzing the field of bispecific antibodies used to…
Biologics sales reach another all time high in 2018 driven by innovative antibodies
April 4, 2018 I We just concluded our annual compilation and analysis of sales of recombinant therapeutic antibodies and proteins…
Further record year of biologics sales in 2018 due to innovative antibodies
STUTTGART, Germany I April 4, 2018 I 2018 was another record year for global sales of branded recombinant therapeutic antibodies…